Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Olsson

Showing results (571-580 of 599) with videos related to

Pageof 60
Sort By:
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
Arthritis and Rheumatism|August 1, 2009
Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritisMichael P M van der Linden, Anouk L Feitsma, Saskia le Cessie, et al.
Respiratory Research|March 29, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertensionChristina A Eichstaedt, Zoe Saßmannshausen, Memoona Shaukat, et al.
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2018
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
Pageof 60

Showing results (571-580 of 599) with videos related to

Sort By:
Pageof 60
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
The American Journal of Pathology|November 29, 2023
Multilamellated Basement Membranes in the Capillary Network of Alveolar Capillary DysplasiaJan C Kamp, Lavinia Neubert, Jonas C Schupp, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
Circulation|April 12, 2024
Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management EraFelix Gerhardt, Eva Fiessler, Karen M Olsson, et al.
International Journal of Cardiology|September 10, 2018
Chronic thromboembolic pulmonary hypertension (CTEPH): Updated Recommendations from the Cologne Consensus Conference 2018Heinrike Wilkens, Stavros Konstantinides, Irene M Lang, et al.
Arthritis and Rheumatism|August 1, 2009
Association of a single-nucleotide polymorphism in CD40 with the rate of joint destruction in rheumatoid arthritisMichael P M van der Linden, Anouk L Feitsma, Saskia le Cessie, et al.
Respiratory Research|March 29, 2022
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertensionChristina A Eichstaedt, Zoe Saßmannshausen, Memoona Shaukat, et al.
The New England Journal of Medicine|September 30, 2025
Sotatercept for Pulmonary Arterial Hypertension within the First Year after DiagnosisVallerie V McLaughlin, Marius M Hoeper, David B Badesch, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|October 9, 2018
Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertensionManuel J Richter, Satenik Harutyunova, Tom Bollmann, et al.
Pageof 60